Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia
Authors:
- Jerome J. SchentagJSJerome J. Schentag
- Andras J. VariAVAndras J. Vari
- Nancy E. WinsladeNWNancy E. Winslade
- Douglas J. SwansonDSDouglas J. Swanson
- Ian L. SmithISIan L. Smith
- Gary W. SimonsGSGary W. Simons
- Alessandra ViganoAVAlessandra Vigano
- 1 February 1985
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 78 (2) , 34-41
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Overwhelming PneumoniaMedical Clinics of North America, 1983
- Nosocomial InfectionsMedical Clinics of North America, 1983
- Novel Resistance Selected by the New Expanded-Spectrum Cephalosporins: A ConcernThe Journal of Infectious Diseases, 1983
- Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infectionsAntimicrobial Agents and Chemotherapy, 1982
- Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patientsAntimicrobial Agents and Chemotherapy, 1982
- Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1982
- In-vivo properties of SQ 26,776Journal of Antimicrobial Chemotherapy, 1981
- Controlled Comparative Trial of Bacampicillin and Amoxicillin in Therapy of Bacterial Infections of the Lower Respiratory TractClinical Infectious Diseases, 1981
- Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapseAntimicrobial Agents and Chemotherapy, 1980
- Deaths from nosocomial infections: Experience in a university hospital and a community hospitalThe American Journal of Medicine, 1980